IMAGEN BIOTECH

Imagen Biotech, Inc. is a private, venture-backed biopharmaceutical company focused on identifying and developing therapeutics for blinding diseases with high unmet medical needs, including dry age-related macular degeneration. Since its formation in the summer of 2011 with financing from SV Life Sciences, Novo Ventures and Fidelity Biosciences, Imagen continues to evaluate numerous compounds sourced worldwide to determine their feasibility as drug development candidates. The Company was co-foun... ded by ophthalmologists Matthew Feinsod, MD, former medical officer at FDA and later SVP with Eyetech Pharmaceuticals, and David Guyer, MD, former founder and CEO of Eyetech Pharmaceuticals and current partner with SV Life Sciences. Imagen is funded to develop approximately three compounds through predetermined milestones.
IMAGEN BIOTECH
Industry:
Biotechnology Health Care Therapeutics
Founded:
2011-06-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.imagenbiotech.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
40 M USD
Technology used in webpage:
Google Apps For Business PHP OpenResty Register.com DNS Network Solutions
Similar Organizations
Galenea
Galenea is engaged in developing therapeutics for central nervous system diseases.
Theragene Pharmaceuticals
Theragene Pharmaceuticals combines innovative science and efficiency to develop life-saving therapies for many debilitating diseases.
Current Employees Featured
Founder
Investors List
F-Prime Capital
F-Prime Capital investment in Series A - Imagen Biotech
Novo Ventures
Novo Ventures investment in Series A - Imagen Biotech
SV Health Investors
SV Health Investors investment in Series A - Imagen Biotech
Official Site Inspections
http://www.imagenbiotech.com
- Host name: 208.91.197.39
- IP address: 208.91.197.39
- Location: British Virgin Islands
- Latitude: 18.5
- Longitude: -64.5
- Timezone: America/Tortola

More informations about "Imagen Biotech"
Imagen Biotech - Crunchbase Company Profile & Funding
Oct 20, 2011 Imagen Biotech, Inc. is a private, venture-backed biopharmaceutical company focused on identifying and developing therapeutics for blinding diseases with high unmet …See details»
Imagen Biotech | Company | Mindmaps
Imagen Biotech, Inc. is a private, venture-backed biopharmaceutical company focused on identifying and developing therapeutics for blinding diseases with high unmet medical needs, …See details»
Imagen Biotech Inc - Company Profile and News - Bloomberg …
Company profile page for Imagen Biotech Inc including stock price, company news, executives, board members, and contact informationSee details»
Imagen Biotech - Company Profile - Tracxn
Imagen Biotech - Developer of therapeutics for blinding diseases including dry age-related macular degeneration. Raised a total funding of $40M over 1 round from 3 investors. Imagen …See details»
Imagen Biotech - Tech Company Profile - Gaebler.com Venture …
Imagen Biotech. Headquartered in New York, Imagen Biotech raised its funding from private investors, Novo Ventures and F-Prime Capital. Company Overview. Company Name. Imagen …See details»
Imagen Biotech - Products, Competitors, Financials, Employees ...
Imagen Biotech is a biopharmaceutical company focused on identifying and developing therapeutics for blinding diseases with unmet medical needs, including dry age-related …See details»
Imagen Biotech, Inc. | VentureRadar
Website: http://www.imagenbiotech.com/ Offers innovative treatments for serious eye diseases, aiming to restore vision and independence for individuals with limited ...See details»
Imagen Biotech - Funding, Financials, Valuation & Investors
Imagen Biotech is focused on identifying and developing therapeutics for blinding diseases. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. ...See details»
Imagen Biotech Inc.
With time to exit an increasingly important metric for VCs, jump-starting new companies via in-licensing remains an important and oft-used strategy. Such derisking is one of the defining …See details»
Imagen Biotech - Contacts, Employees, Board Members
Organization. Imagen Biotech . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 2. About. …See details»
Imagen Biotech - VentureRadar
Similar Companies: Tepnel Life Sciences United Kingdom n/a Tepnel Life Sciences is a leading provider of nucleic acid purification solutions to the BioMedical research market. Its range …See details»
Imagen Biotech CEO, Founder, Key Executive Team, Board of …
Explore {Imagen Biotech's key management people. Discover current leadership team members including founders, CEO, other executives and board directors.See details»
Eyetech vets launch Imagen Biotech with $40M A round
Oct 20, 2011 SV Life Sciences, Novo Ventures and Fidelity Biosciences joined forces to launch a new drug developer, Imagen Biotech, with "up to" $40 million in venture bucks to finance …See details»
What is Imagen Biotech? Company Culture, Mission, Values
See what employees say it's like to work at Imagen Biotech. Salaries, reviews, and more - all posted by employees working at Imagen Biotech.See details»
Imagen Biotech Closes $40 Mln In Financing
Oct 19, 2011 Imagen Biotech said Wednesday that it has received up to $40 million in Series A financing from SV Life Sciences, Novo Ventures, and Fidelity Biosciences. Imagen Biotech is …See details»
Imagen Biotech main corporate video - YouTube
Video about Imagen Biotech's high content screening services. The video explains what High Content Analysis is and what services we at Imagen Biotech offer.See details»
MD, Co-founder, Chief Medical Officer - Crunchbase
Primary Organization . Imagen Biotech . Location Rockville, Maryland, United States; ... Imagen Biotech MD, Co-founder, Chief Medical Officer. Related Hubs. Edit Related Hubs Section. Hub …See details»
Imagen Biotech Banks $40 Million to Advance Ophthalmology …
Imagen Biotech, Inc. recently announced it has secured up to $40 million in Series A financing from SV Life Sciences, Novo Ventures, and Fidelity Biosciences to pursue the identification …See details»
Imagen Therapeutics Company Profile 2024: Valuation, Funding ...
Imagen Therapeutics General Information Description. Developer of oncological therapies designed to provide treatment for cancer. The company's platform improves outcomes for …See details»
Imagen Biotech Ltd - Manchester, United Kingdom - bionity.com
Everyday, we help scientists to speed up their research, improve their efficiency and increase their output. Why Imagen Biotech? As the only dedicated High Content Biology company in …See details»